These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25466394)

  • 1. Does young age influence the prognosis of colorectal cancer: a population-based analysis.
    McKay A; Donaleshen J; Helewa RM; Park J; Wirtzfeld D; Hochman D; Singh H; Turner D
    World J Surg Oncol; 2014 Dec; 12():370. PubMed ID: 25466394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
    Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
    Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location.
    Golan T; Urban D; Berger R; Lawrence YR
    Cancer; 2013 Aug; 119(16):3084-91. PubMed ID: 23720150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains.
    Kneuertz PJ; Chang GJ; Hu CY; Rodriguez-Bigas MA; Eng C; Vilar E; Skibber JM; Feig BW; Cormier JN; You YN
    JAMA Surg; 2015 May; 150(5):402-9. PubMed ID: 25806815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of prognostic factors in colorectal carcinoma.
    Deliu IC; Georgescu EF; Bezna MC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):808-16. PubMed ID: 25341305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: a population-based study.
    Iachetta F; Reggiani Bonetti L; Marcheselli L; Di Gregorio C; Cirilli C; Messinese S; Cervo GL; Postiglione R; Di Emidio K; Pedroni M; Longinotti E; Federico M; Ponz de Leon M
    Acta Oncol; 2013 Nov; 52(8):1682-90. PubMed ID: 23786176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
    Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.
    Ahmed S; Leis A; Fields A; Chandra-Kanthan S; Haider K; Alvi R; Reeder B; Pahwa P
    Cancer; 2014 Mar; 120(5):683-91. PubMed ID: 24222180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multivariate analysis of prognostic factors in colorectal cancer patients with different ages].
    Cai SR; Zheng S; Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):483-5. PubMed ID: 16188146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.
    Inoue Y; Iwata T; Okugawa Y; Kawamoto A; Hiro J; Toiyama Y; Tanaka K; Uchida K; Mohri Y; Miki C; Kusunoki M
    Oncology; 2013; 84(2):100-7. PubMed ID: 23147449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel data-driven prognostic model for staging of colorectal cancer.
    Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
    J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
    Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
    Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after hepatic resection in metastatic colorectal cancer: a population-based study.
    Cummings LC; Payes JD; Cooper GS
    Cancer; 2007 Feb; 109(4):718-26. PubMed ID: 17238180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in survival of colorectal cancer patients after surgery.
    Mehrkhani F; Nasiri S; Donboli K; Meysamie A; Hedayat A
    Colorectal Dis; 2009 Feb; 11(2):157-61. PubMed ID: 18462239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer.
    Lim SB; Yu CS; Jang SJ; Kim TW; Kim JH; Kim JC
    Dis Colon Rectum; 2010 Apr; 53(4):377-84. PubMed ID: 20305435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
    Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
    J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.